Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT01455051
Status:
COMPLETED
Last Update Posted:
2022-05-06
First Post:
2011-10-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation
Sponsor:
Grupo Espanol de trasplantes hematopoyeticos y terapia celular
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GETH-CLL4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |